Recording of the webinar "Long term outcomes of CAR T-cell therapy in myeloma. During this webinar you will hear about the long-term efficacy and safety data from clinical trials of CAR T-cell therapies in myeloma, and what recovery, long term monitoring and side-effect management may look like. This presentation is given by Dr. Hermann Einsele, from the University of Würzburg in Germany, and David Williams, a myeloma patient, who received CAR T-cell therapy three years ago.
[00:10] Introduction with Dominic Candea
[04:37] Long-term outcomes of CAR T-cell therapy in myeloma with Dr Hermann Einsele
[32:18] David’s CAR T-cell journey with David Williams
[41:41] Q&A
[00:10] Introduction with Dominic Candea
[04:37] Long-term outcomes of CAR T-cell therapy in myeloma with Dr Hermann Einsele
[32:18] David’s CAR T-cell journey with David Williams
[41:41] Q&A
-
MPE webinar | Long term outcomes of CAR T-cell therapy in myeloma
-
Generics Market in cancer treatment webinar
-
EYMPG webinar Mental health and emotional wellbeing
-
Post ASH Webinar - ASH 2025 myeloma highlights
-
Webinar EYMPG | Side effects and management of myeloma treatment
-
ASCERTAIN webinar | How are costs and medicine effectiveness part of decision-making in access?
-
MPE webinar Myeloma and infection
-
European Young Myeloma Patients Group | Latest developments in treatments for young myeloma patients
-
MPE Webinar | EHA 2025 highlights
-
MPE webinar | Living well with AL amyloidosis
-
Webinar | ‘How do different countries make decisions on reimbursing new medicines?’
-
Webinar EYMPG | Myeloma and physical fitness